Bio-Rad LaboratoriesFRA:BUWA -0.15%72 Quick Ratio is 2.37 as of Mar. 2026, which is 25% below its 10-year median of 3.18. GuruFocus rates FRA:BUWA with a GF Score™ of 72/100 and a GF Value™ of €276.61 (Fairly Valued). The stock has 5 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Bio-Rad Laboratories ranks better than 59.72% on this metric.
Bio-Rad Laboratories has a quick ratio of 2.37. It generally indicates good short-term financial strength.
The historical rank and industry rank for Bio-Rad Laboratories's Quick Ratio or its related term are showing as below:
FRA:BUWA'
s Quick Ratio Range Over the Past 10 Years
Min: 1.62 Med: 3.18 Max: 4.89
Current: 2.37
During the past 13 years, Bio-Rad Laboratories's highest Quick Ratio was 4.89. The lowest was 1.62. And the median was 3.18.
FRA:BUWA's Quick Ratio is ranked better than 59.72% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.865
vs FRA:BUWA: 2.37
Bio-Rad Laboratories (FRA:BUWA) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Bio-Rad Laboratories Quick Ratio Related Terms
Bio-Rad Laboratories Quick Ratio Historical Data
* Premium members only.
The historical data trend for Bio-Rad Laboratories's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:BUWA vs GKOS, BRKR, PODD: Quick Ratio Comparison
For the Medical Devices subindustry, Bio-Rad Laboratories's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Rad Laboratories Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Bio-Rad Laboratories's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Bio-Rad Laboratories's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Rad Laboratories (FRA:BUWA) has a Quick Ratio of 2.37 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Bio-Rad Laboratories and its competitors. This is 25% below median its historical median of 3.18. Over the past decade, Bio-Rad Laboratories' Quick Ratio has ranged from 1.62 to 4.89. According to the industry distribution chart, Bio-Rad Laboratories ranks #344 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 40.3%.
Is Bio-Rad Laboratories' Quick Ratio too high?
Bio-Rad Laboratories' current Quick Ratio of 2.37 is 25% below median its 10-year median of 3.18. Over the past 10 years, this metric has ranged from a low of 1.62 to a high of 4.89. The Medical Devices & Instruments industry median Quick Ratio is 1.87. Bio-Rad Laboratories' value of 2.37 is 27.1% above this industry median. Based on the distribution chart, Bio-Rad Laboratories ranks #344 out of 854 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Bio-Rad Laboratories has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bio-Rad Laboratories' Quick Ratio compare to GKOS and BRKR?
According to the Medical Devices & Instruments industry distribution chart, Bio-Rad Laboratories ranks #344 out of 854 companies for Quick Ratio. This puts Bio-Rad Laboratories in the upper half of its industry. The industry median Quick Ratio is 1.87. Bio-Rad Laboratories' value of 2.37 is 27.1% above this benchmark. Historically, Bio-Rad Laboratories' own Quick Ratio has ranged from 1.62 to 4.89 over the past decade. While the company's 10-year median is 3.18 vs. the industry median of 1.87, Bio-Rad Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio-Rad Laboratories's current Quick Ratio of 2.37 is 27.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Bio-Rad Laboratories and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio-Rad Laboratories's current Quick Ratio is 2.37, which is 25% below median its own 10-year median of 3.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Rad Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Bio-Rad Laboratories (FRA:BUWA) is currently considered Fairly Valued. The stock's GF Value™ is €276.61, compared to a current price of €261.60 — trading 5.4% below its estimated fair value. The current Quick Ratio is 2.37, which is 25% below median its 10-year median of 3.18 and 27.1% above the Medical Devices & Instruments industry median of 1.87. Bio-Rad Laboratories' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Bio-Rad Laboratories (FRA:BUWA), the current Quick Ratio is 2.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio-Rad Laboratories (FRA:BUWA) Overvalued in 2026?
Based on GuruFocus' analysis, Bio-Rad Laboratories stock appears to be undervalued.
The current stock price of €261.60 is trading 5.4% below its estimated GF Value™ of €276.61.
GuruFocus considers Bio-Rad Laboratories to be Fairly Valued.
Key valuation signals for FRA:BUWA:
Quick Ratio: 2.37 (25% below median its 10-year median of 3.18)
GF Value™: €276.61 vs. price of €261.60 (5.4% below fair value)
Industry Position: 27.1% above the Medical Devices & Instruments median (#344 of 854)
No single metric tells the full story. See the FRA:BUWA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
72GF Score
Get the complete analysis for FRA:BUWA
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:BUWA has been successfully added to your 
